RG
AGN

Redmile Group’s Allergan plc AGN Stock Holding History

Redmile Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,200
Closed -$292K – 76
2017
Q2 		$292K Buy
+1,200
New +$282K 0.02% 58
2016
Q2 		– Sell
-114,448
Closed -$30.7M – 62
2016
Q1 		$30.7M Buy
114,448
+45,690
+66% +$13.1M 3.14% 11
2015
Q4 		$21.5M Buy
+68,758
New +$20.5M 1.61% 23
2015
Q3 		– Sell
-136,818
Closed -$41.5M – 72
2015
Q2 		$41.5M Buy
+136,818
New +$40.8M 3.4% 6
2014
Q4 		– Sell
-163,898
Closed -$39.5M – 67
2014
Q3 		$39.5M Sell
163,898
-12,800
-7% -$2.86M 4.57% 3
2014
Q2 		$39.4M Sell
176,698
-69,700
-28% -$14.4M 4.78% 1
2014
Q1 		$50.7M Buy
246,398
+74,158
+43% +$14.7M 6.06% 1
2013
Q4 		$28.9M Sell
172,240
-99,260
-37% -$15.5M 3.57% 6
2013
Q3 		$39.1M Buy
+271,500
New +$36.2M 5.89% 1

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Redmile Group's AGN Position: Q3 2017 in Review

Redmile Group sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,200 shares — an estimated $292K sold.

Redmile Group first reported a position in AGN in Q3 2013 and held it in 9 quarters. The position peaked at $50.7M in Q1 2014. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Redmile Group reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Redmile Group sold 1,200 Allergan plc shares in Q3 2017, an estimated $292K.
  • Redmile Group first reported a position in Allergan plc in Q3 2013 and held it in 9 quarters.
  • Redmile Group's Allergan plc position peaked at $50.7M in Q1 2014.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Redmile Group's 13F filing for Q3 2017, filed 14 Nov 2017.